Trending Now
AstraZeneca’s Imfinzi, tremelimumab fail to improve OS versus chemotherapy in bladder cancer study
AstraZeneca's Imfinzi, tremelimumab fail to improve OS versus chemotherapy in bladder cancer study
Orexo Submits Application for vorvida to the FDA to Enable Commercialization in the US
Orexo Submits Application for vorvida to the FDA to Enable Commercialization in the US
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio...
ADVANZ PHARMA Corp. Limited Announces Definitive Agreement to Acquire The Rights To A Portfolio Of Alprostadil Products From UCB S.A. For Approximately $84 Million
Pfizer weighs working with BioNTech on potential coronavirus vaccine ...
Pfizer weighs working with BioNTech on potential coronavirus vaccine ...
Open Orphan: New hVIVO contract signed with a European Biotech Company
Open Orphan: New hVIVO contract signed with a European Biotech Company
